» Articles » PMID: 10534321

Prediction of Human Clearance of Twenty-nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of in Vitro Half-life Approach and Nonspecific Binding to Microsomes

Overview
Specialty Pharmacology
Date 1999 Oct 26
PMID 10534321
Citations 308
Authors
Affiliations
Soon will be listed here.
Abstract

Twenty-nine drugs of disparate structures and physicochemical properties were used in an examination of the capability of human liver microsomal lability data ("in vitro T(1/2)" approach) to be useful in the prediction of human clearance. Additionally, the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated. The compounds examined demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 ml/min/kg to 189 ml/min/kg. Microsomal binding was determined at microsomal protein concentrations used in the lability incubations. For the 29 compounds studied, unbound fractions in microsomes ranged from 0.11 to 1.0. Generally, basic compounds demonstrated the greatest extent of binding and neutral and acidic compounds the least extent of binding. In the projection of human clearance values, basic and neutral compounds were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions. Including only blood binding yielded very poor projections of human clearance for these two types of compounds. However, for acidic compounds, disregarding all binding considerations yielded poor predictions of human clearance. It was generally most difficult to accurately predict clearance for this class of compounds; however the accuracy was best when all binding considerations were included. Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.

Citing Articles

DigiLoCS: A leap forward in predictive organ-on-chip simulations.

Aravindakshan M, Mandal C, Pothen A, Schaller S, Maass C PLoS One. 2025; 20(1):e0314083.

PMID: 39787162 PMC: 11717216. DOI: 10.1371/journal.pone.0314083.


Determination of Intrinsic Clearance and Fraction Unbound in Human Liver Microsomes and In Vitro-In Vivo Extrapolation of Human Hepatic Clearance for Marketed Central Nervous System Drugs.

Palacharla V, Nirogi R, Kumar N, Nandakumar K Eur J Drug Metab Pharmacokinet. 2024; 50(2):119-135.

PMID: 39724218 DOI: 10.1007/s13318-024-00931-2.


Pre-ADMET studies of 5-(3',4'-dihydroxyphenyl)-γ-valerolactone, the bioactive intestinal metabolite of proanthocyanidins.

Della Vedova L, Husain I, Wang Y, Kothapalli H, Gado F, Baron G Arch Pharm (Weinheim). 2024; 358(1):e2400575.

PMID: 39526505 PMC: 11726150. DOI: 10.1002/ardp.202400575.


Prediction of Pharmacokinetic Drug-Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic Modeling.

Bu F, Cho Y, He Q, Wang X, Howlader S, Kim D Drug Des Devel Ther. 2024; 18:4585-4600.

PMID: 39429896 PMC: 11490238. DOI: 10.2147/DDDT.S480402.


Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase Inhibitors.

Tyagarajan S, Andrews C, Beshore D, Buevich A, Curran P, Dandliker P ACS Med Chem Lett. 2024; 15(10):1787-1794.

PMID: 39411537 PMC: 11472384. DOI: 10.1021/acsmedchemlett.4c00345.